4.6 Article

HIV-1 Vpr Protein Inhibits Telomerase Activity via the EDD-DDB1-VPRBP E3 Ligase Complex

期刊

JOURNAL OF BIOLOGICAL CHEMISTRY
卷 288, 期 22, 页码 15474-15480

出版社

AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
DOI: 10.1074/jbc.M112.416735

关键词

-

资金

  1. Duncan Family Institute research program grant
  2. University Cancer Foundation Grant [IRG-08-061-01]
  3. American Association for Cancer Research-Pancreatic Cancer Action Network [11-20-25-PARK]
  4. Center for Stem Cell and Developmental Biology transformative pilot grant
  5. Metastasis Research Center grant
  6. University of Texas MD Anderson Cancer Center
  7. National Institutes of Health through The University of Texas MD Anderson Cancer Center [CA016672]

向作者/读者索取更多资源

Viral pathogens utilize host cell machinery for their benefits. Herein, we identify that HIV-1 Vpr (viral protein R) negatively modulates telomerase activity. Telomerase enables stem and cancer cells to evade cell senescence by adding telomeric sequences to the ends of chromosomes. We found that Vpr inhibited telomerase activity by down-regulating TERT protein, a catalytic subunit of telomerase. As a molecular adaptor, Vpr enhanced the interaction between TERT and the VPRBP substrate receptor of the DYRK2-associated EDD-DDB1-VPRBP E3 ligase complex, resulting in increased ubiquitination of TERT. In contrast, the Vpr mutant identified in HIV-1-infected long-term nonprogressors failed to promote TERT destabilization. Our results suggest that Vpr inhibits telomerase activity by hijacking the host E3 ligase complex, and we propose the novel molecular mechanism of telomerase deregulation in possibly HIV-1 pathogenesis.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据